$ATEX

Lang Scott A. sold $3.2M of ATEX

Lang Scott A. (President and CEO) sold 35,057 shares of Anterix Inc. (ATEX) at an average of $90.22 ($88.96–$91.69, $3.16M total) across 4 trades on 2026-08-14.

Original reporting
SEC EDGAR · Lang Scott A.
Published Aug 17, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ATEX
Neutral
medium confidence
Mentioned
$ATEX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATEXNeutralLow
01

Why it matters

Traders may reassess short-term sentiment around ATEX due to the CEO’s $3.16M sale, but there is no accompanying fundamental catalyst in the text.

02

Market read

A CEO insider sale at roughly $90/share is newly disclosed, but the filing contains no guidance, deal, or operational update.

03

What to watch

The text notes no pre-arranged 10b5-1 plan, which can amplify interpretation risk; however, the filing does not provide motive, tax context, or whether sales were part of a broader compensation schedule.

Relevance 6/10Novelty 5/10Timing: filed after-hours on 2026-08-17, reflecting trades dated 2026-08-14

Background

The article is a SEC Form 4 insider transaction disclosure for Anterix Inc. (ATEX), listing CEO Lang Scott’s open-market sales.

Company-level read

Ticker impact

$ATEXNeutralMedium confidence
Context

Anterix CEO Lang Scott sold about $3.16M of ATEX shares in open-market trades at roughly $88.96 to $91.69 per share.

Expected impact

Near-term sentiment impact is likely limited; any reaction would be more about optics than new company-specific fundamentals.

Evidence & confidence

This is a Form 4 insider transaction with disclosed sale size and price range, but it provides no new guidance, contracts, or operational updates. The absence of a stated 10b5-1 plan in the text can increase attention, yet insider sales are often routine.

Market effects

Limited sector read-through; insider-sale optics typically do not reset sector expectations without accompanying operational news.

No clear regional spillover indicated by the filing alone.

No global market linkage beyond company-specific sentiment.

Counterpoint

The CEO sale could be planned for liquidity or diversification and may not signal reduced confidence, especially given multi-trade execution over a narrow price band.

Key entities

  • Anterix Inc.

    Public company whose CEO insider sale is disclosed via Form 4.

  • Lang Scott A.

    President and CEO who sold 35,057 ATEX shares across four trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Anterix Inc. Reports First Quarter Fiscal Year 2027 Results Woodland Park, NJ – August 11, 2026 – Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026. Financial and Operational Highlights –

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-20260331xpressrelease.htm EX-99.1 Document Anterix Inc. Reports Full Fiscal Year 2026 Results Woodland Park, NJ – June 10, 2026 – Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2